Available On-Demand



Strengthening Corporate Growth Through Mid-Term Innovation

Are you ready to take your MedTech or Life Sciences company to the next level? High-growth companies dominate their markets, seize new opportunities, and gain financial flexibility to innovate fearlessly. But how can you sustain growth in today’s competitive landscape?

Join Triple Ring and LSX as experts share strategies to accelerate growth in MedTech and Life Sciences through innovation, partnerships, and creative deal structures.

What You’ll Learn:

  • Find out how build-to-buy and shared-risk models can help you innovate faster while minimizing financial risks.
  • Learn to combine internal R&D strengths with external partnerships to unlock new growth opportunities.
  • Explore real-world applications of shared-risk strategies in cutting-edge fields like neurotechnology, robotics, digital health, and precision health.
  • Uncover ways to leverage mid-term innovation projects to drive sustainable, long-term success.
  • Gain insights into creative financing solutions, including Venture Capital and Private Equity, to support your innovation goals.

Sponsored by:

Speakers:


Ryan McGuinness (Moderator)
Chief Growth Officer
Triple Ring


Joe Heanue
Co-Founder and CEO
Triple Ring


John Pennet
Partner-in-Charge of the Technology and Life Sciences practice
Eisner Advisory Group LLC


Francois Valencony
Chief Investment & Business Officer
General Inception


Stephen Thau
Partner, Co-Head Life Sciences
Orrick

Register below: